Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Thermo Fisher ScientificBSP:TMOS34 +2.36%77 Days Sales Outstanding is 71.68 as of Jun. 2026, which is 15% above its 10-year median of 62.24. GuruFocus rates BSP:TMOS34 with a GF Score™ of 77/100 and a GF Value™ of R$63.73 (Fairly Valued). The stock has 10 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks worse than 55.94% on this metric.
The historical rank and industry rank for Thermo Fisher Scientific's Days Sales Outstanding or its related term are showing as below:
BSP:TMOS34'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.87 Med: 62.24 Max: 70.99
Current: 70.99
During the past 13 years, Thermo Fisher Scientific's highest Days Sales Outstanding was 70.99. The lowest was 55.87. And the median was 62.24.
BSP:TMOS34's Days Sales Outstanding is ranked worse than 55.94% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.855
vs BSP:TMOS34: 70.99
Thermo Fisher Scientific's Days Sales Outstanding
declined
from Jun. 2025 (73.03) to Jun. 2026 (71.68).
Thermo Fisher Scientific (BSP:TMOS34) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thermo Fisher Scientific Days Sales Outstanding Related Terms
Thermo Fisher Scientific Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Thermo Fisher Scientific's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific Days Sales Outstanding Chart
BSP:TMOS34 vs DHR, IDXX, A: Days Sales Outstanding Comparison
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific Days Sales Outstanding vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's Days Sales Outstanding falls into.
Thermo Fisher Scientific Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (BSP:TMOS34) has a Days Sales Outstanding of 71.68 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Thermo Fisher Scientific and its competitors. This is 15% above median its historical median of 62.24. Over the past decade, Thermo Fisher Scientific's Days Sales Outstanding has ranged from 55.87 to 70.99. According to the industry distribution chart, Thermo Fisher Scientific ranks #113 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 55.9%.
Is Thermo Fisher Scientific's Days Sales Outstanding too high?
Thermo Fisher Scientific's current Days Sales Outstanding of 71.68 is 15% above median its 10-year median of 62.24. Over the past 10 years, this metric has ranged from a low of 55.87 to a high of 70.99. The Medical Diagnostics & Research industry median Days Sales Outstanding is 67.86. Thermo Fisher Scientific's value of 71.68 is 5.6% above this industry median. Based on the distribution chart, Thermo Fisher Scientific ranks #113 out of 202 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Thermo Fisher Scientific has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Days Sales Outstanding compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #113 out of 202 companies for Days Sales Outstanding. This places Thermo Fisher Scientific in the lower half of its industry. The industry median Days Sales Outstanding is 67.86. Thermo Fisher Scientific's value of 71.68 is 5.6% above this benchmark. Historically, Thermo Fisher Scientific's own Days Sales Outstanding has ranged from 55.87 to 70.99 over the past decade. While the company's 10-year median is 62.24 vs. the industry median of 67.86, Thermo Fisher Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Diagnostics & Research company?
The median Days Sales Outstanding among Medical Diagnostics & Research companies is 67.86, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thermo Fisher Scientific's current Days Sales Outstanding of 71.68 is 5.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Thermo Fisher Scientific and its competitors. For the Medical Diagnostics & Research industry, the median Days Sales Outstanding is 67.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thermo Fisher Scientific's current Days Sales Outstanding is 71.68, which is 15% above median its own 10-year median of 62.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Fairly Valued. The stock's GF Value™ is R$63.73, compared to a current price of R$67.27 — trading 5.6% above its estimated fair value. The current Days Sales Outstanding is 71.68, which is 15% above median its 10-year median of 62.24 and 5.6% above the Medical Diagnostics & Research industry median of 67.86. Thermo Fisher Scientific's overall GF Score™ is 77/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current Days Sales Outstanding is 71.68 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?
Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be overvalued.
The current stock price of R$67.27 is trading 5.6% above its estimated GF Value™ of R$63.73.
GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.
Key valuation signals for BSP:TMOS34:
Days Sales Outstanding: 71.68 (15% above median its 10-year median of 62.24)
GF Value™: R$63.73 vs. price of R$67.27 (5.6% above fair value)
Industry Position: 5.6% above the Medical Diagnostics & Research median (#113 of 202)
No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
77GF Score
Get the complete analysis for BSP:TMOS34
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:TMOS34 has been successfully added to your 
